Nuclear medicine is a multidisciplinary field that develops
and uses instrumentation and tracers (radiopharmaceuticals) to study
physiological processes and noninvasively diagnose, stage, and treat diseases.
Particularly, it offers a unique means to study cancer biology in vivo and to
optimize cancer therapy for individual patients. Nuclear medicine imaging,
including single-photon emission computer tomography (SPECT) and positron
emission tomography (PET-CT), can provide important functional information and
quantitative about normal tissues or disease conditions, in contrast to
conventional, anatomical imaging techniques.
The role of nuclear medicine in cancer therapy involves use
of tumor-targeting agents, conjugated with therapeutic radionuclides, used to
deposit lethal radiation at tumor & metastatic sites.
The Nuclear Medicine department is
backed by highly trained and experienced Nuclear Medicine Physicians and
Physicist/RSO specialised in the field of Nuclear Medicine. It is equipped with
68Ga generator that helps in-house
radiopharmaceutical formulation of 68Ga-PSMA/DOTA. The department has
successfully started 177-Lu PSMA Therapy for the first time in Central India.
SPECT-CT: Bone Scan, Renal Scan, Thyroid Scan, Iodine scan, Cardiac
Scan, Para Thyroid Scan, Sentinel Node Mapping, Lung Ventilation/Perfusion
Scan, Brain Scan, Liver Scan, Hepatobiliary Scan, GI Bleed Scan, Meckel’s
Diverticulum Scan, Gastric Emptying Scan, Salivary Gland Scan,
Lymphoscintigraphy, Bone Marrow Imaging, Infection/Inflammation Imaging.
WB PET CT Scan (18F-FDG & 68Ga-PSMA/DOTA)
Cardiac PET CT Scan
Lutetium (177Lu-PSMA/DOTA) Therapy – For Carcinoma Prostate
High dose Radioiodine Therapy (131-I) – for Well differentiated
Low dose Radioiodine Therapy (131-I) – for treating
Hyperactive thyroid gland
131-I MIBG Therapy – for Neuroblastoma
Bone Pain Palliation Therapy (153-Sm, 177Lu-EDTMP)